These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 3097100

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [New thrombolytic agents in myocardial infarction].
    Charbonnier B, Lang M, Brochier M.
    Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222
    [Abstract] [Full Text] [Related]

  • 3. New developments in thrombolytic therapy.
    Collen D, Gold HK.
    Adv Exp Med Biol; 1990 Nov; 281():333-54. PubMed ID: 2129372
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The search for the ideal thrombolytic agent.
    Verstraete M.
    J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):4B-10B. PubMed ID: 2959714
    [Abstract] [Full Text] [Related]

  • 6. Comparison of thrombolytic, fibrinolytic, and fibrinogenolytic properties of tissue plasminogen activator, streptokinase, single-chain urokinase, high molecular weight and low molecular weight urokinase in human plasma in vitro.
    Samama M, Nguyen G, Desnoyers P, Lourenco DM, Fretault J, Horellou MH, Conard J, Szwarcer E, Verdy E, Vahanian A.
    Fundam Clin Pharmacol; 1988 Nov; 2(6):509-23. PubMed ID: 3149257
    [Abstract] [Full Text] [Related]

  • 7. Thrombolytic therapy.
    Collen D, Stump DC, Gold HK.
    Annu Rev Med; 1988 Nov; 39():405-23. PubMed ID: 3130773
    [Abstract] [Full Text] [Related]

  • 8. New developments in thrombolytic therapy.
    Collen DC, Gold HK.
    Thromb Res Suppl; 1990 Nov; 10():105-31. PubMed ID: 2180114
    [Abstract] [Full Text] [Related]

  • 9. The nature of synergy between tissue-type and single chain urokinase-type plasminogen activators.
    Fry ET, Mack DL, Sobel BE.
    Thromb Haemost; 1989 Nov 24; 62(3):909-16. PubMed ID: 2512679
    [Abstract] [Full Text] [Related]

  • 10. [Structure, function and use of fibrinolysis-promoting and inhibiting factors].
    Bachmann F.
    Arzneimittelforschung; 1988 Mar 24; 38(3A):474-8. PubMed ID: 3134901
    [Abstract] [Full Text] [Related]

  • 11. Coronary thrombolysis with clot-selective plasminogen activators.
    Collen D, Bounameaux H.
    Herz; 1986 Feb 24; 11(1):9-15. PubMed ID: 3082731
    [Abstract] [Full Text] [Related]

  • 12. [Thrombolytics and their use].
    Alessi MC, Juhan-Vague I.
    Rev Prat; 1999 Oct 01; 49(15):1654-8. PubMed ID: 10581996
    [Abstract] [Full Text] [Related]

  • 13. Molecular mechanism of action of newer thrombolytic agents.
    Collen D.
    J Am Coll Cardiol; 1987 Nov 01; 10(5 Suppl B):11B-15B. PubMed ID: 3117858
    [Abstract] [Full Text] [Related]

  • 14. Preclinical pharmacological evaluation of anisoylated plasminogen streptokinase activator complex.
    Ferres H.
    Drugs; 1987 Nov 01; 33 Suppl 3():33-50. PubMed ID: 3315613
    [Abstract] [Full Text] [Related]

  • 15. Synergy of in vitro thrombolytic action of combinations of recombinant staphylokinase and single-chain urokinase-type plasminogen activator.
    Aisina RB, Moukhametova LI, Varfolomeyev SD.
    Biochemistry (Mosc); 2003 Nov 01; 68(11):1252-60. PubMed ID: 14640969
    [Abstract] [Full Text] [Related]

  • 16. Tissue-type plasminogen activator (t-PA) and single chain urokinase-type plasminogen activator (scu-PA): potential for fibrin-specific thrombolytic therapy.
    Collen D.
    Prog Hemost Thromb; 1986 Nov 01; 8():1-18. PubMed ID: 3104986
    [No Abstract] [Full Text] [Related]

  • 17. Synergism of tissue-type plasminogen activator (t-PA) and single-chain urokinase-type plasminogen activator (scu-PA) on clot lysis in vitro and a mechanism for this effect.
    Gurewich V, Pannell R.
    Thromb Haemost; 1987 Jun 03; 57(3):372-3. PubMed ID: 3116707
    [No Abstract] [Full Text] [Related]

  • 18. Fibrinolytic agents: mechanisms of activity and pharmacology.
    Lijnen HR, Collen D.
    Thromb Haemost; 1995 Jul 03; 74(1):387-90. PubMed ID: 8578491
    [Abstract] [Full Text] [Related]

  • 19. Fibrin-specific thrombolytic agents.
    Collen D.
    Schweiz Med Wochenschr; 1987 Nov 14; 117(46):1791-8. PubMed ID: 3122317
    [Abstract] [Full Text] [Related]

  • 20. Comparative thrombolytic properties of single-chain forms of urokinase-type plasminogen activator.
    Stump DC, Stassen JM, Demarsin E, Collen D.
    Blood; 1987 Feb 14; 69(2):592-6. PubMed ID: 3099862
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.